MedTrace Logo

Stroke in Working Age and Job Accommodation in Facilitating Transition Back to Work

NCT06709898 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-03-13

No results posted yet for this study

Summary

The aim of this randomized controlled trial (RCT) is to investigate whether cognitive job accommodation intervention enhances return to work, work ability and performance after ischemic stroke in working-age population. The main questions are:

* Does the cognitive job accommodation intervention affect absenteeism and presenteeism after stroke?
* Does the intervention affect work ability and perceived cognitive and emotional difficulties at work?
* Does the intervention decrease mental strain, fatigue and negative mood symptoms after return to work?
* Does the intervention affect life satisfaction among the stroke patients returning to work?

Researchers will compare the intervention group to a control group returning to work after stroke with current healthcare practices and work procedures.

Participants:

* At baseline, 6 and 12 month follow-up web-based questionnaires and cognitive tests are administered.
* At 3 month follow-up participants fill in Brain Work Questionnaire (BWQ) that measures cognitive demands and difficulties at work.

Conditions

Interventions

OTHER

Cognitive job accommodation

Job accommodation focused on the cognitive aspects at work

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • Finnish Work Environment Fund

    collaborator OTHER

  • Finnish Institute of Occupational Health

    lead OTHER

Principal Investigators

  • Teemu I Paajanen, Dr · Finnish Institute of Occupational Health

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-10
Primary Completion
2026-12-31
Completion
2027-06-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06709898 on ClinicalTrials.gov